- Home
- SMSI vs TRIB Comparison
SMSI vs TRIB Comparison
Compare SMSI & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- TRIB
- Stock Information
- Founded
- SMSI 1982
- TRIB 1992
- Country
- SMSI United States
- TRIB Ireland
- Employees
- SMSI N/A
- TRIB N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SMSI Technology
- TRIB Health Care
- Exchange
- SMSI Nasdaq
- TRIB Nasdaq
- Market Cap
- SMSI 24.7M
- TRIB 25.5M
- IPO Year
- SMSI 1995
- TRIB N/A
- Fundamental
- Price
- SMSI $0.76
- TRIB $0.59
- Analyst Decision
- SMSI Strong Buy
- TRIB
- Analyst Count
- SMSI 1
- TRIB 0
- Target Price
- SMSI $5.00
- TRIB N/A
- AVG Volume (30 Days)
- SMSI 301.5K
- TRIB 37.2K
- Earning Date
- SMSI 05-07-2025
- TRIB 05-22-2025
- Dividend Yield
- SMSI N/A
- TRIB N/A
- EPS Growth
- SMSI N/A
- TRIB N/A
- EPS
- SMSI N/A
- TRIB N/A
- Revenue
- SMSI $20,555,000.00
- TRIB $59,126,000.00
- Revenue This Year
- SMSI $36.40
- TRIB $11.63
- Revenue Next Year
- SMSI $46.07
- TRIB $10.13
- P/E Ratio
- SMSI N/A
- TRIB N/A
- Revenue Growth
- SMSI N/A
- TRIB N/A
- 52 Week Low
- SMSI $0.52
- TRIB $0.56
- 52 Week High
- SMSI $3.21
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- SMSI 34.47
- TRIB 36.73
- Support Level
- SMSI $0.75
- TRIB $0.56
- Resistance Level
- SMSI $0.89
- TRIB $0.71
- Average True Range (ATR)
- SMSI 0.07
- TRIB 0.04
- MACD
- SMSI 0.01
- TRIB -0.01
- Stochastic Oscillator
- SMSI 28.33
- TRIB 15.62
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. It offers multi-platform, modular solutions such as SafePath; CommSuite; and ViewSpot. The company's only reportable segment is Wireless. Its Wireless segment sells to large wireless carriers, cable operators, and OEMs.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.